25 related articles for article (PubMed ID: 9663372)
1. Cost analysis of aprotinin for coronary artery bypass patients: analysis of the randomized trials.
Smith PK; Datta SK; Muhlbaier LH; Samsa G; Nadel A; Lipscomb J
Ann Thorac Surg; 2004 Feb; 77(2):635-42; discussion 642-3. PubMed ID: 14759451
[TBL] [Abstract][Full Text] [Related]
2. A model of the direct and indirect effects of aprotinin administration on the overall costs of coronary revascularization surgery in a university teaching hospital cardiothoracic unit.
Robinson D; Bliss E
Clin Ther; 2002 Oct; 24(10):1677-89. PubMed ID: 12462296
[TBL] [Abstract][Full Text] [Related]
3. Randomized, placebo-controlled, double-blind study of an ultra-low-dose aprotinin regimen in reoperative and/or complex cardiac operations.
Hardy JF; Bélisle S; Couturier A; Robitaille D
J Card Surg; 1997; 12(1):15-22. PubMed ID: 9169364
[TBL] [Abstract][Full Text] [Related]
4. The efficacy and cost of aprotinin in children undergoing reoperative open heart surgery.
D'Errico CC; Shayevitz JR; Martindale SJ; Mosca RS; Bove EL
Anesth Analg; 1996 Dec; 83(6):1193-9. PubMed ID: 8942585
[TBL] [Abstract][Full Text] [Related]
5. Aprotinin reduces bleeding and blood product use in patients treated with clopidogrel before coronary artery bypass grafting.
Lindvall G; Sartipy U; van der Linden J
Ann Thorac Surg; 2005 Sep; 80(3):922-7. PubMed ID: 16122456
[TBL] [Abstract][Full Text] [Related]
6. The effect on costs of the use of half-dose aprotinin for first-time reoperative coronary artery bypass patients.
Able ME; Tilly DA
Clin Ther; 1998; 20(3):581-91. PubMed ID: 9663372
[TBL] [Abstract][Full Text] [Related]
7. Aprotinin: an update of its pharmacology and therapeutic use in open heart surgery and coronary artery bypass surgery.
Peters DC; Noble S
Drugs; 1999 Feb; 57(2):233-60. PubMed ID: 10188764
[TBL] [Abstract][Full Text] [Related]
8. Review and application of serine protease inhibition in coronary artery bypass graft surgery.
Engles L
Am J Health Syst Pharm; 2005 Sep; 62(18 Suppl 4):S9-14. PubMed ID: 16227196
[TBL] [Abstract][Full Text] [Related]
9. Role of aprotinin in the management of patients during and after cardiac surgery.
Punjabi PP; Wyse RK; Taylor KM
Expert Opin Pharmacother; 2000 Dec; 1(7):1353-65. PubMed ID: 11249470
[TBL] [Abstract][Full Text] [Related]
10. The efficacy and safety of aprotinin use in cardiac surgery.
Rich JB
Ann Thorac Surg; 1998 Nov; 66(5 Suppl):S6-11; discussion S25-8. PubMed ID: 9869434
[TBL] [Abstract][Full Text] [Related]
11. Aprotinin dosing: how much is enough?
Niimi KS
J Extra Corpor Technol; 2004 Dec; 36(4):384-90. PubMed ID: 15679284
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
